European Journal of Pharmacology 1991: Vol 192 Index

14 Pages·1991·4.4 MB·English

European Journal of Pharmacology, 192 (1991) 449-452
© 1991 Elsevier Science Publishers B.V. (Biomedical Division) 0014-2999 /91 /$03.50
Author index
Abe, Y., Kitada, Y., Narimatsu, A. and Tobe, A. Mechanism of blockade by (+)isradipine of adrenal catechol-
Improvement of postischemic contractile dysfunction of dog heart amine release (192) 243
by MCI-154, a novel cardiotonic agent (192) 279 Carlson, S., see Pertovaara, A. (192) 349
Ahrén, B., see Ar’Rajab, A. (192) 443 Casas, M., see Ferré, S. (192) 25
Alabadi, J.A., see Salom, J.B. (192) 39 Casas, M., see Ferré, S. (192) 31
Alborch, E., see Salom, J.B. (192) 39 Cavallotti, C., see De Michele, M. (192) 71
Al-Mashhadani, W.M., Karim, K.H., Al-Taie, R.I. and Al-Zahawi, Chapman, I.D., see Small, R.C. (192) 417
H.M. Chariot, J., see Tazi-Saad, K. (192) 271
Nifedipine versus cimetidine in prevention of stress-induced gastric Charlton, P.A., see Gardner, C.J. (192) 329
ulcers in rats (192) 117 Cherry, P.C., see Gardner, C.J. (192) 329
Al-Taie, R.I., see Al-Mashhadani, W.M. (192) 117 Chiba, T., see Maggi, C.A. (192) 85
Altavilla, D., see Squadrito, F. (192) 47 Church, J., Millar, J.D., Jones, M.G. and Lodge, D.
Alvarez, C., see Salom, J.B. (192) 39 NMDA receptor antagonist effects of the stereoisomers of B-
Al-Zahawi, H.M., see Al-Mashhadani, W.M. (192) 117 cyclazocine in rats, in vivo and in vitro (192) 337
Amenta, F., Ricci, A. and Vega, J.A. Cierpial, M.A., see Weiss, J.M. (192) 177
Autoradiographic localization of dopamine receptors in rat cerebral Coop, C.F., McNaughton, N. and Lambie, I.
blood vessels (192) 123 Effects of GABA, and GABAg receptor agonists on reticular-
Amenta, F., see De Michele, M. (192) 71 elicited hippocampal rhythmical slow activity (192) 103
Amobi, N. and Smith, I.C.H. Cotman, C.W., see Bridges, R.J. (192) 199
Paradoxical effects of thioridazine on electromechanical coupling Crankshaw, D., see Maurice, D.H. (192) 235
in the human and rat vas deferens (192) 343 Cusack, B., see Bolden, C. (192) 205
Andén, N.-E., see Ferré, S. (192) 25
Andén, N.-E., see Ferré, S. (192) 31
De Jong, W., see Arakawa, K. (192) 311
Angst, C., see Sills, M.A. (192) 19 De Jong, W., see Petty, M.A. (192) 383
Arakawa, K., De Jong, W., Mulder, A.H. and Versteeg, D.H.G.
Del Tacca, M., see Tazi-Saad, K. (192) 271
The electrically stimulated release of [*H]noradrenaline from
De Michele, M., Cavallotti, C. and Amenta, F.
nucleus tractus solitarii slices in vitro is modulated via p-opioid
Autoradiographic localization of muscarinic acetylcholine recep-
receptors (192) 311
tors in the rat pulmonary vascular tree (192) 71
Arena, A., see Squadrito, F. (192) 47
Devaud, L.L. and Hollingsworth, E.B.
Ar’Rajab, A. and Ahrén, B.
Effects of the 5-HT, receptor antagonist, ritanserin, on biogenic
Effects of amidated rat islet amyloid polypeptide on glucose-
amines in the rat nucleus accumbens (192) 427
stimulated insulin secretion in vivo and in vitro in rats (192) 443
Domenech, R., Macho, P., Gonzalez, R. and Huidobro-Toro, J.P.
Barbieri, A., see Grana, E. (192) 79 Effect of endothelin on total and regional coronary resistance and
Beaujouan, J.-C., see Petitet, F. (192) 203 on myocardial contractility (192) 409
Berry, J.L., see Small, R.C. (192) 417 Doods, H., Entzeroth, M. and Mayer, N.
Bjur, R.A., see Shinozuka, K. (192) 431 Cardioselectivity of AQ-RA 741, a novel tricyclic antimuscarinic
Bolden, C., Cusack, B. and Richelson, E. drug (192) 147
Clozapine is a potent and selective muscarinic antagonist at the Dow, J., see Petty, M.A. (192) 383
five cloned human muscarinic acetylcholine receptors expressed in Duan, J. and Moffat, M.P.
CHO-K1 cells (192) 205 Protective effects of D,L-carnitine against arrhythmias induced by
lysophosphatidylcholine or reperfusion (192) 355
Bouysset, F., see Vayssettes-Courchay, C. (192) 389
Bowen, W.D., see Mattia, A. (192) 371 Dudley, D.J., see Mitchell, M.D. (192) 189
Boyle, J.P., see Small, R.C. (192) 417
Bridges, R.J., Koh, J.-y., Hatalski, C.G. and Cotman, C.W. Edwin, S.S., see Mitchell, M.D. (192) 189
Increased excitotoxic vulnerability of cortical cultures with re- Elliott, K.R.F., see Small, R.C. (192) 417
duced levels of glutathione (192) 199 Entzeroth, M., see Doods, H. (192) 147
Brundish, D.E., see Sills, M.A. (192) 19
Bueno, L., Fargeas, M.J., Theodorou, V. and Fioramonti, J.
Fagg, G., see Sills, M.A. (192) 19
Involvement of 5-hydroxytryptamine in the intestinal motor dis-
Fargeas, M.J., see Bueno, L. (192) 263
turbances induced by mast cell degranulation in rats (192) 263
Ferré, S., Herrera-Marschitz, M., Grabowska-Andén, M., Casas, M..,
Calixto, J.B. and Rae, G.A. Ungerstedt, U. and Andén, N.-E.
Effects of endothelins, Bay K 8644 and other oxytocics in non- Postsynaptic dopamine/adenosine interaction: II. Postsynaptic
pregnant and late pregnant rat isolated uterus (192) 109 dopamine agonism and adenosine antagonism of methylxanthines
Campo, G.M., see Squadrito, F. (192) 47 in short-term reserpinized mice (192) 31
Caputi, A.P., see Squadrito, F. (192) 47 Ferré, S., Herrera-Marschitz, M., Grabowska-Andén, M., Ungerstedt,
Cardenas, A.M., Montiel, C., Garcia, A.G., Michelena, P. and U., Casas, M. and Andén, N.-E.
Sanchez-Garcia, P. Postsynaptic dopamine/adenosine interaction: I. Adenosine ana-
450
logues inhibit dopamine D,-mediated behaviour in short-term Kamiya, H.-o., see Hagio, T. (192) 173
reserpinized mice (192) 25 Kanda, K., Miyamoto, N., Seo, H., Ogawa, K., Hatano, T. and
Fioramonti, J., see Bueno, L. (192) 263 Matsui, N.
Fisher, B., Zornow, M.H., Yaksh, T.L. and Peterson, B.M. Diuretics modify [Arg®]vasopressin-stimulated cAMP but not atrial
Antinociceptive properties of intrathecal dexmedetomidine in rats natriuretic peptide-stimulated cGMP formation in renal cells (192)
(192) 221 153
Forest, M.C., see Lacroix, P. (192) 317 Karim, K.H., see Al-Mashhadani, W.M. (192) 117
Foster, R.W., see Small, R.C. (192) 417 Kawano, K.-i., see Takayanagi, I. (192) 97
Fournié-Zaluski, M.C., see Schmidt, C. (192) 253 Keith, R.A., see Mangano, T.J. (192) 9
Fredow, G. and Léscher, W. ; Kendig, J.J., Savola, M.K.T., Woodley, S.J. and Maze, M.
Effects of pharmacological manipulation of GABAergic neuro- a>-Adrenoceptors inhibit a nociceptive response in neonatal rat
transmission in a new mutant hamster model of paroxysmal spinal cord (192) 293
dystonia (192) 207 Kitada, Y., see Abe, Y. (192) 279
Fredow, G., see Léscher, W. (192) 377 Ko, F.-N., Lin, C.-N., Liou, S.-S., Huang, T.-F. and Teng, C.-M.
Frew, R., see Lundy, P.M. (192) 439 Vasorelaxation of rat thoracic aorta caused by norathyriol isolated
Frye, G.D. from Gentianaceae (192) 133
Interaction of ethanol and L-glutamate in the guinea pig ileum Koerner, J.F., see Whittemore, E.R. (192) 435
myenteric plexus (192) 1 Koh, J.-y., see Bridges, R.J. (192) 199
Koike, K., see Takayanagi, I. (192) 97
Kumei, Y., see Uehara, A. (192) 185
Gallagher, J.P., see Twery, M.J. (192) 287
Ganter, M., see Léscher, W. (192) 377
Garcia, A.G., see Cardenas, A.M. (192) 243
Lachance, D. and Garcia, R.
Garcia, R., see Lachance, D. (192) 301
Atrial natriuretic factor and volume expansion-induced natriuresis
Gardner, C.J., Twissell, D.J., Charlton, P.A. and Cherry, P.C.
in the spontaneously hypertensive rat (192) 301
Acute and chronic effects of renin inhibitor GR70982 in the
Lacroix, P., Linee, P. and Forest, M.C.
conscious marmoset (192) 329
Diproteverine (BRL 40015): a new type of calcium antagonist with
Giuliani, S., see Maggi, C.A. (192) 85
potential antianginal properties (192) 317
Glowinski, J., see Petitet, F. (192) 203
Lambie, I., see Coop, C.F. (192) 103
Gonzalez, R., see Domenech, R. (192) 409
Laubie, M., see Vayssettes-Courchay, C. (192) 389
Grabowska-Andén, M., see Ferré, S. (192) 25
Leitold, M., see Zimmermann, T. (192) 181
Grabowska-Andeén, M., see Ferré, S. (192) 31
Liljequist, S.
Grana, E., Barbieri, A. and Zonta, F.
The competitive NMDA receptor antagonist, CGP 39551, inhibits
Effects of cromakalim (BRL 34915) on mechanical responses of
ethanol withdrawal seizures (192) 197
rat vas deferens to noradrenaline and naphazoline (192) 79
Lin, C.-N., see Ko, F.-N. (192) 133
Grisar, J.M., see Petty, M.A. (192) 383
Linee, P., see Lacroix, P. (192) 317
Liou, S.-S., see Ko, F.-N. (192) 133
Lodge, D., see Church, J. (192) 337
Hagio, T., Takano, Y., Nagashima, A., Nakayama, Y., Tateishi, K.
Léscher, W., Fredow, G. and Ganter, M.
and Kamiya, H.-o.
Comparison of pharmacodynamic effects of the non-competitive
The central pressor actions of a novel tachykinin peptide, y-pre-
NMDA receptor antagonists MK-801 and ketamine in pigs (192)
protachykinin-(72-92)-peptide amide (192) 173
377
Harajiri, S.-i., see Yamada, S. (192) 141
Léscher, W., see Fredow, G. (192) 207
Haslam, R.J., see Maurice, D.H. (192) 235
Lundy, P.M. and Frew, R.
Hatalski, C.G., see Bridges, R.J. (192) 199
The effect of neuropeptide Y on voltage-sensitive Ca?* channels
Hatano, T., see Kanda, K. (192) 153
(192) 439
Haynes, L.
B-Endorphin C-terminal peptide evokes arachidonic acid release
from cortical neurones (192) 397
Macho, P., see Domenech, R. (192) 409
Henry, J.L., see Hong, Y. (192) 55
Maggi, C.A., Chiba, T. and Giuliani, S.
Herrera-Marschitz, M., see Ferré, S. (192) 25
Human a-calcitonin gene-related peptide-(8-37) as an antagonist
Herrera-Marschitz, M., see Ferré, S. (192) 31
of exogenous and endogenous calcitonin gene-related peptide (192)
Hilaire, G., see Morin, D. (192) 89
85
Hollingsworth, E.B., see Devaud, L.L. (192) 427
Hong, Y. and Henry, J.L. Malik, K.U., see Jaiswal, N. (192) 63
Cardiovascular responses to intrathecal administration of L- and Mangano, T.J., Patel, J., Salama, A.I. and Keith, R.A.
Inhibition of K*-evoked [*H]D-aspartate release and neuronal
D-baclofen in the rat (192) 55
calcium influx by verapamil, diltiazem and dextromethorphan:
Huang, T.-F., see Ko, F.-N. (192) 133
evidence for non-L/non-N voltage-sensitive calcium channels (192)
Huidobro-Toro, J.P., see Domenech, R. (192) 409
9
Hurt, S.D., see Sills, M.A. (192) 19
Martin, P. and Puech, A.J.
Is there a relationship between 5-HT,, receptors and the mecha-
Jackson, C.B., see Sancilio, L.F. (192) 365 nisms of action of antidepressant drugs in the learned helplessness
Jaiswal, N. and Malik, K.U. paradigm in rats? (192) 193
Methoctramine, a cardioselective antagonist: muscarinic receptor Matsui, N., see Kanda, K. (192) 153
mediating prostaglandin synthesis in isolated rabbit heart (192) 63 Mattia, A., Vanderah, T., Mosberg, H.I., Omnaas, J.R., Bowen, W.D.
Johnson, S.M., see Pillai, N.P. (192) 227 and Porreca, F.
Jones, M.G., see Church, J. (192) 337 Pharmacological characterization of [D-Ala*,Leu>,Ser° Jenkephalin
(DALES): antinociceptive actions at the 6,6n-complexed"OPioid re- Salama, A.I., see Mangano, T.J. (192) 9
ceptor (192) 371 Salom, J.B., Torregrosa, G., Miranda, F.J., Alabadi, J.A., Alvarez, C.
Maurice, D.H., Crankshaw, D. and Haslam, R.J. and Alborch, E.
Synergistic actions of nitrovasodilators and isoprenaline on rat Effects of endothelin-1 on the cerebrovascular bed of the goat
aortic smooth muscle (192) 235 (192) 39
Maurice, T. and Vignon, J. Sanchez-Garcia, P., see Cardenas, A.M. (192) 243
Desipramine and the phencyclidine derivative BTCP differently Sancilio, L.F., Pinkus, L.M., Jackson, C.B. and Randall Munson, Jr.,
inhibit [7H]TCP binding to high- and low-affinity sites (192) 169 H.
Mayer, N., see Doods, H. (192) 147 Studies on the emetic and antiemetic properties of zacopride and
Maze, M., see Kendig, J.J. (192) 293 its enantiomers (192) 365
McNaughton, N., see Coop, C.F. (192) 103 Santoro, G., see Squadrito, F. (192) 47
Mecke, E., see Pertovaara, A. (192) 349 Sasamata, M., see Yamamoto, M. (192) 165
Michelena, P., see Cardenas, A.M. (192) 243 Savola, M.K.T., see Kendig, J.J. (192) 293
Millar, J.D., see Church, J. (192) 337 Schiller, S.L., see Mitchell, M.D. (192) 189
Miranda, F.J., see Salom, J.B. (192) 39 Schmidt, C., Peyroux, J., Noble, F., Fournié-Zaluski, M.C. and
Mitchell, M.D., Dudley, D.J., Edwin, S.S. and Schiller, S.L. Roques, B.P.
Interleukin-6 stimulates prostaglandin production by human am- Analgesic responses elicited by endogenous enkephalins (protected
nion and decidual cells (192) 189 by mixed peptidase inhibitors) in a variety of morphine-sensitive
Miyamoto, N., see Kanda, K. (192) 153 noxious tests (192) 253
Moffat, M.P., see Duan, J. (192) 355 Schmitt, H., see Vayssettes-Courchay, C. (192) 389
Monteau, R., see Morin, D. (192) 89 Schwabe, U., see Wilken, A. (192) 161
Montiel, C., see Cardenas, A.M. (192) 243 Sedaa, K.O., see Shinozuka, K. (192) 431
Morin, D., Monteau, R. and Hilaire, G. Seo, H., see Kanda, K. (192) 153
5-Hydroxytryptamine modulates central respiratory activity in the Shinozuka, K., Sedaa, K.O., Bjur, R.A. and Westfall, D.P.
newborn rat: an in vitro study (192) 89 Participation by purines in the modulation of norepinephrine
Mosberg, H.I., see Mattia, A. (192) 371 release by methoxamine ' (192) 431
Mulder, A.H., see Arakawa, K. (192) 311 Sills, M.A., Fagg, G., Pozza, M., Angst, C., Brundish, D.E., Hurt,
S.D., Wilusz, E.J. and Williams, M.
Nagashima, A., see Hagio, T. (192) 173 [7H]CGP 39653: a new N-methyl-D-aspartate antagonist radio-
Nakayama, Y., see Hagio, T. (192) 173 ligand with low nanomolar affinity in rat brain (192) 19
Namiki, M., see Uehara, A. (192) 185 Small, R.C., Berry, J.L., Boyle, J.P., Chapman, I.D., Elliott, K.R.F.,
Narimatsu, A., see Abe, Y. (192) 279 Foster, R.W. and Watt, A.J.
Nebel, U., see Wermelskirchen, D. (192) 403 Biochemical and electrical aspects of the tracheal relaxant action
Nishi, S., see Yamada, S. (192) 141 of AH 21-132 (192) 417
Noble, F., see Schmidt, C. (192) 253 Smith, I.C.H., see Amobi, N. (192) 343
Squadrito, F., Sturniolo, R., Altavilla, D., Santoro, G., Campo, G.M.,
Ogawa, K., see Kanda, K. (192) 153 Arena, A. and Caputi, A.P.
Okumura, T., see Uehara, A. (192) 185 Platelet activating factor involvement in splanchnic artery occlu-
Omnaas, J.R., see Mattia, A. (192) 371 sion shock in rats (192) 47
Sturniolo, R., see Squadrito, F. (192) 47
Patel, J., see Mangano, T.J. (192) 9 Sudoh, K., see Yamamoto, M. (192) 165
Pertovaara, A., Mecke, E. and Carlson, S. Sundar, S.K., see Weiss, J.M. (192) 177
Attempted reversal of cocaine-induced antinociceptive effects with
naloxone, an opioid antagonist (192) 349 Takano, Y., see Hagio, T. (192) 173
Peterson, B.M., see Fisher, B. (192) 221 Takasugi, Y., see Uehara, A. (192) 185
Petitet, F., Glowinski, J. and Beaujouan, J.-C. Takayanagi, I., Kawano, K.-i. and Koike, K.
Evoked release of acetylcholine in the rat striatum by stimulation Effects of aging on a,-adrenoceptor mechanisms in isolated
of tachykinin NK-1 receptors (192) 203 guinea-pig tracheal preparations (192) 97
Petty, M.A., Dow, J., Grisar, JM. and De Jong, W. Tateishi, K., see Hagio, T. (192) 173
Effect of a cardioselective a-tocopherol analogue on reperfusion Tawfik-Schlieper, H., see Wilken, A. (192) 161
injury in rats induced by myocardial ischaemia (192) 383 Tazi-Saad, K., Chariot, J., Vatier, J., Del Tacca, M. and Rozé, C.
Peyroux, J., see Schmidt, C. (192) 253 Antisecretory and anti-ulcer effects of morphine in rats after
Pillai, N.P. and Johnson, S.M. gastric mucosal aggression (192) 271
The electrophysiological effects of [D-Ala*,N-Me-Phe*,Gly°-ol]en- Teng, C.-M., see Ko, F.-N. (192) 133
kephalin on guinea-pig myenteric neurons (192) 227 Theodorou, V., see Bueno, L. (192) 263
Pinkus, L.M., see Sancilio, L.F. (192) 365 Tobe, A., see Abe, Y. (192) 279
Porreca, F., see Mattia, A. (192) 371 Torregrosa, G., see Salom, J.B. (192) 39
Pozza, M., see Sills, M.A. (192) 19 Twery, M.J., Wong, L.A. and Gallagher, J.P.
Puech, A.J., see Martin, P. (192) 193 Somatostatin induced hyperpolarization of septal neurons is not
blocked by pertussis toxin (192) 287
Rae, G.A., see Calixto, J.B. (192) 109 Twissell, D.J., see Gardner, C.J. (192) 329
Randall Munson, Jr., H., see Sancilio, L.F. (192) 365
Ricci, A., see Amenta, F. (192) 123 Uehara, A., Okumura, T., Kumei, Y., Takasugi, Y. and Namiki, M.
Richelson, E., see Bolden, C. (192) 205 Indomethacin reverses interleukin-1-induced hyperinsulinemia in
Ritchie, J.C., see Weiss, J.M. (192) 177 conscious and freely moving rats (192) 185
Roques, B.P., see Schmidt, C. (192) 253 Ungerstedt, U., see Ferré, S. (192) 25
Rozé, C., see Tazi-Saad, K. (192) 271 Ungerstedt, U., see Ferré, S. (192) 31
452
Vanderah, T., see Mattia, A. (192) 371 Williams, M., see Sills, M.A. (192) 19
Vatier, J., see Tazi-Saad, K. (192) 271 Wilusz, E.J., see Sills, M.A. (192) 19
Vayssettes-Courchay, C., Bouysset, F., Verbeuren, T.J., Laubie, M. Wirth, A., see Wermelskirchen, D. (192) 403
and Schmitt, H. Wong, L.A., see Twery, M.J. (192) 287
Quipazine-induced hypertension in anaesthetized cats is mediated Woodley, S.J., see Kendig, J.J. (192) 293
by central and peripheral 5-HT, receptors: role of the ventro-
lateral pressor area (192) 389
Vega, J.A., see Amenta, F. (192) 123
Yaksh, T.L., see Fisher, B. (192) 221
Verbeuren, T.J., see Vayssettes-Courchay, C. (192) 389
Yamada, S., Yokoo, H., Harajiri, S.-i. and Nishi, S.
Versteeg, D.H.G., see Arakawa, K. (192) 311
Alterations in dopamine release from striatal slices of rats after
Vignon, J., see Maurice, T. (192) 169
chronic treatment with haloperidol (192) 141
Yamamoto, M., Sudoh, K. and Sasamata, M.
Watt, A.J., see Small, R.C. (192) 417
Effects of YM-14673, a new thyroid-releasing hormone analogue,
Weiss, J.M., Sundar, S.K., Cierpial, M.A. and Ritchie, J.C.
on neurological deficits in stroke-prone spontaneously hyperten-
Effects of interleukin-1 infused into brain are antagonized by
sive rats (192) 165
a-MSH in a dose-dependent manner (192) 177
Yeates, R.A., see Zimmermann, T. (192) 181
Wermelskirchen, D., Nebel, U., Wirth, A. and Wilffert, B.
Yokoo, H., see Yamada, S. (192) 141
*Ca?+ movements induced by Ca’* chloride in isolated rat aorta
Youdim, M.B.H.
under K *-free conditions (192) 403
Modulation of monoamine oxidase a activity in PC12 cells by
Westfall, D.P., see Shinozuka, K. (192) 431
steroids (192) 201
Whittemore, E.R. and Koerner, J.F.
Pre-exposure to L-homocysteinesulfinic acid blocks quisqualate-
induced sensitization to L-2-amino-4-phosphonobutanoic acid
(192) 435 Zimmermann, T., Leitold, M. and Yeates, R.A.
Wilffert, B., see Wermelskirchen, D. (192) 403 Comparison of isobutyl nitrate and isobutyl nitrite: tolerance and
Wilken, A., Tawfik-Schlieper, H. and Schwabe, U. cross-tolerance to glyceryl trinitrate (192) 181
Evidence against the presence of A, adenosine receptors on guinea Zonta, F., see Grana, E. (192) 79
pig ventricular myocytes (192) 161 Zornow, M.H., see Fisher, B. (192) 221
European Journal of Pharmacology, 192 (1991) 453-461 453
© 1991 Elsevier Science Publishers B.V. (Biomedical Division) 0014-/2919 /9$039.5 0
Key word index
ACTH cAMP
Interleukin-1; a-MSH (a-melanocyte-stimulating hormone); Corti- Diuretics (low ceiling); Diuretics (high ceiling); [Arg®]vasopressin
costeroids; Immunosuppression; Natural Killer cell activity (Weiss, (AVP); Renal cells (cultured, rat); Renal cells (cultured, dog) (Kanda,
J.M. (192) 177) K. (192) 153)
Adenine nucleosides Adenosine receptors; Cardiomyocytes (Wilken, A. (192) 161)
Artery (caudal); Norepinephrine; Neuromodulation; Methoxamine;
Analgesia
Adenine nucleotides (Shinozuka, K. (192) 431)
a-Adrenoceptor agonists; Analgesics; Clonidine; a-Adrenoceptors;
Dexmedetomidine; Spinal cord (neonatal rat) (Kendig, J.J. (192) 293)
Adenine nucleotides
Artery (caudal); Norepinephrine; Neuromodulation; Methoxamine;
Cocaine; Naloxone; Thalamus; Formalin test; Pain (mechanical);
Adenine nucleosides (Shinozuka, K. (192) 431)
(Rat) (Pertovaara, A. (192) 349)
Adenosine analogues
Analgesics
Reserpine; Bromocriptine; Locomotor activity; (Mouse) (Ferré, S.
a-Adrenoceptor agonists; Analgesia; Clonidine; a-Adrenoceptors;
(192) 25)
Dexmedetomidine; Spinal cord (neonatal rat) (Kendig, J.J. (192) 293)
Adenosine receptors
ANF (atrial natriuretic factor)
Cardiomyocytes; cAMP (Wilken, A. (192) 161)
Spontaneously hypertensive rats (SHR); Volume expansion; Atrial
pressure; Na* excretion; Hydralazine (Lachance, D. (192) 301)
Adrenal medulla
Isradipine; Catecholamine release (Cardenas, A.M. (192) 243) Antidepressant drugs
Learned helplessness; 5-HT,, receptor agonists; (Rats) (Martin, P.
a-Adrenoceptor agonists (192) 193)
Analgesia; Analgesics; Clonidine; a-Adrenoceptors; Dexmedetomi-
dine; Spinal cord (neonatal rat) (Kendig, J.J. (192) 293) Antinociception
Dexmedetomidine; a,-Adrenoceptors; (Intrathecal) (Fisher, B. (192)
a-Adrenoceptors 221)
a-Adrenoceptor agonists; Analgesia; Analgesics; Clonidine; Dex-
medetomidine; Spinal cord (neonatal rat) (Kendig, J.J. (192) 293) Enkephalin metabolism; Morphine; Kelatorphan; Naloxone; RB 38A
inhibitors (mixed); (Mouse); (Rat) (Schmidt, C. (192) 253)
a,-Adrenoceptors
Aorta (rat)
Dexmedetomidine; Antinociception; (Intrathecal) (Fisher, B. (192)
*Ca?+ uptake; Ca** channels (leakage); Ca?* entry blockers
221)
(Wermelskirchen, D. (192) 403)
Nucleus tractus solitarii slices; [7H]Noradrenaline release; Clonidine;
Aortic strips (rabbit)
Yohimbine; Opioid receptor agonists (selective); u-Opioid receptors;
Isobutyl nitrate; Isobutyl nitrite; Glyceryl trinitrate; Tolerance (in
(Rat) (Arakawa, K. (192) 311)
vitro) (Zimmermann, T. (192) 181)
Afferents (primary)
AQ-RA 741
CGRP (calcitonin gene-related peptide); CGRP receptor antagonists;
Muscarinic M,_ receptors; Cardioselective muscarinic receptor
Capsaicin; Efferent function of sensory nerves (Maggi, C.A. (192) 85)
antagonists (Doods, H. (192) 147)
AH 21-132 (and enantiomers) Arachidonic acid
Trachealis muscle (guinea-pig); Muscle fibres (skinned); Phos- Glycyl-L-glutamine; Proopiomelanocortin peptides; NMDA (N-
phodiesterase inhibition; Nucleotides (cyclic); Electrophysiology methyl-D-aspartate); Phencyclidine/o receptors; Cultured neurones
(Small, R.C. (192) 417)
(Haynes, L. (192) 397)
L-2-Amino-4-phosphonebutanoic acid (L-AP4) Arterial pressure
Quisqualic acid; Sensitization; Hippocampal slices; Excitatory amino Baclofen; GABA (y-aminobutyric acid); Cardiovascular control; Spi-
acids (Whittemore, E.R. (192) 435) nal cord; Sympathetic output; Heart rate (Hong, Y. (192) 55)
Amnion Artery (caudal)
Interleukin-6; Prostaglandin biosynthesis; Decidua; Labour (Mitchell, Norepinephrine; Neuromodulation; Methoxamine; Adenine nucleo-
M.D. (192) 189) tides; Adenine nucleosides (Shinozuka, K. (192) 431)
454
Aspirin Ca** channels (leakage)
Gastric acid secretion; Ulceration; Gastric mucus; Morphine; In- “Ca?+ uptake; Aorta (rat); Ca?* entry blockers (Wermelskirchen, D.
domethacin; Taurocholic acid (Tazi-Saad, K. (192) 271) (192) 403)
Atrial pressure Ca** channels (voltage-sensitive)
ANF (atrial natriuretic factor); Spontaneously hypertensive rats Neuropeptide Y; Ca** influx (Lundy, P.M. (192) 439)
(SHR); Volume expansion; Na* excretion; Hydralazine (Lachance,
D. (192) 301) Ca”* entry blockers
“Ca?+ uptake; Ca** channels (leakage); Aorta (rat) (Wermels-
Automaticity kirchen, D. (192) 403)
Lysophosphatidylcholine; Carnitine; Reperfusion arrhythmias; Cou-
pled beats (Duan, J. (192) 355) Ca**-free media
Smooth muscle; Vas deferens (human); Vas deferens (rat); Electro-
Autoradiography mechanical coupling; Thioridazine (Amobi, N. (192) 343)
Muscarinic acetylcholine receptors; Hypertension; Pulmonary artery;
Pulmonary vein (De Michele, M. (192) 71) Ca** influx
Vasorelaxation (rat aorta); Norathyriol; cGMP (Ko, F.-N. (192) 133)
Dopamine DA, receptors; Dopamine DA, receptors; Circle of Willis
arteries; Pial-arachnoid arteries; Radioreceptor binding (Amenta, F. Ca** channels (voltage-sensitive); Neuropeptide Y (Lundy, P.M.
(192) 123) (192) 439)
Baclofen Calcium channels (voltage-sensitive)
GABA (y-aminobutyric acid); Cardiovascular control; Spinal cord; Verapamil; Diltiazem; Dextromethorphan; Neurotransmitter release;
Sympathetic output; Heart rate; Arterial pressure (Hong, Y. (192) 55) w-Conotoxin GVIA (Mangano, T.J. (192) 9)
Dystonia; GABA (y-aminobutyric acid); Diazepam; Valproate; Phe- Capsaicin
nobarbital; Phenytoin; Carbamazepine; Pentylenetetrazol (Fredow, CGRP (calcitonin gene-related peptide); CGRP receptor antagonists;
G. (192) 207) Afferents (primary); Efferent function of sensory nerves (Maggi, C.A.
(192) 85)
BAY k 8644
Cerebral arteries; Blood flow (cerebral); Endothelium; Ca?*; Carbamazepine
Nicardipine (Salom, J.B. (192) 39) Dystonia; GABA (y-aminobutyric acid); Diazepam; Valproate; Phe-
nobarbital; Phenytoin; Baclofen; Pentylenetetrazol (Fredow, G. (192)
Endothelins; Oxytocic agents; Uterus (rat); Nicardipine; Pregnancy 207)
(Calixto, J.B. (192) 109)
Cardiac muscarinic M ,, receptors
Benzamides Methoctramine; Muscarinic receptor subtypes; Cardioselectivity;
Zacopride; Emesis; 5-HT receptor antagonists; (Ferret); (Stereoiso- Prostaglandin synthesis (Jaiswal, N. (192) 63)
mers) (Sancilio, L.F. (192) 365)
Cardiomyocytes
Blood flow (cerebral) Adenosine receptors; cAMP (Wilken, A. (192) 161)
Cerebral arteries; Endothelium; Ca?*; Nicardipine; BAY k 8644
(Salom, J.B. (192) 39) Cardioselective muscarinic receptor antagonists
AQ-RA 741; Muscarinic M, receptors (Doods, H. (192) 147)
Bromocriptine
Reserpine; Adenosine analogues; Locomotor activity; (Mouse) (Ferré, Cardioselectivity
S. (192) 25) Methoctramine; Muscarinic receptor subtypes; Cardiac muscarinic
M,,, receptors; Prostaglandin synthesis (Jaiswal, N. (192) 63)
Reserpine; Methylxanthines; NECA (5’-(N-ethyl)carboxamido-
adenosine); Locomotor activity; (Mouse) (Ferré, S. (192) 31) Cardiotonic agents
MCI-154; Reperfusion; Postischemic dysfunction; (Dog) (Abe, Y.
BrX-537 A (192) 279)
Mast cells; Compound 48/80; 5-HT (5-hydroxytryptamine, sero-
tonin); 5-HT receptor; Small intestine; Motility (Bueno, L. (192) 263) Cardiovascular control
Baclofen; GABA (y-aminobutyric acid); Spinal cord; Sympathetic
BTCP (N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine) output; Heart rate; Arterial pressure (Hong, Y. (192) 55)
[7HJTCP ({?H]N-{1-(2-thienyl)cyclohexyl]-3,4-piperidine) (in vivo
binding); Desipramine; Tricyclic antidepressants; Phencyclidine; Cardiovascular regulation
NMDA (N-methyl-D-aspartate) (Maurice, T. (192) 169) Substance P; Neuropeptide y; Tachykinin peptides (Hagio, T. (192)
173)
Ca?*
Cerebral arteries; Blood flow (cerebral); Endothelium; Nicardipine; Carnitine
BAY k 8644 (Salom, J.B. (192) 39) Lysophosphatidylcholine; Reperfusion arrhythmias; Coupled beats;
Automaticity (Duan, J. (192) 355)
Ca** channel antagonists
Diproteverine; Haemodynamic effects; Coronary flow redistribution; Catecholamine release
Myocardial metabolism (Lacroix, P. (192) 317) Isradipine; Adrenal medulla (Cardenas, A.M. (192) 243)
455
“Ca?* uptake Cromakalim
Ca** channels (leakage); Aorta (rat); Ca** entry blockers Vas deferens (rat); Noradrenaline; Naphazoline; Verapamil; K*
(Wermelskirchen, D. (192) 403) channels (Grana, E. (192) 79)
Cerebral arteries Cultured neurones
Blood flow (cerebral); Endothelium; Ca?*; Nicardipine; BAY k 8644 Glycyl-L-glutamine; Arachidonic acid; Proopiomelanocortin peptides;
(Salom, J.B. (192) 39) NMDA (N-methyl-D-aspartate); Phencyclidine/o receptors (Haynes,
L. (192) 397)
CGRP (calcitonin gene-related peptide)
Cyclazocine
CGRP receptor antagonists; Capsaicin; Afferents (primary); Efferent
Phencyclidine; NMDA receptors (Church, J. (192) 337)
function of sensory nerves (Maggi, C.A. (192) 85)
Cyclooxygenase inhibitors
CGRP receptor antagonists
Indomethacin; Insulin; Interleukin-1; Prostaglandin; (Rat) (Uehara,
CGRP (calcitonin gene-related peptide); Capsaicin; Afferents
A. (192) 185)
(primary); Efferent function of sensory nerves (Maggi, C.A. (192) 85)
DALES ({D-Ala”,Leu>,Ser® Jenkephalin)
Cimetidine
Opioid antinociception; 5-Opioid receptors; p-Opioid receptors; En-
Mast cells; Nifedipine; Stress ulcers (Al-Mashhadani, W.M. (192)
kephalins; (Intracerebroventricular) (Mattia, A. (192) 371)
117)
Decidua
Circle of Willis arteries Interleukin-6; Prostaglandin biosynthesis; Amnion; Labour (Mitchell,
Dopamine DA, receptors; Dopamine DA, receptors; Pial-arachnoid M.D. (192) 189)
arteries; Radioreceptor binding; Autoradiography (Amenta, F. (192)
123) Desipramine
[SH]TCP ({?HJN-[1-(2-thienyl)cyclohexyl]-3,4-piperidine) (in vivo
Clonidine binding); Tricyclic antidepressants; BTCP (N-[1-(2-benzo(b)thio-
a-Adrenoceptor agonists; Analgesia; Analgesics; a-Adrenoceptors; phenyl)cyclohexyl]piperidine); Phencyclidine; NMDA (N-methyl-D-
Dexmedetomidine; Spinal cord (neonatal rat) (Kendig, J.J. (192) 293) aspartate) (Maurice, T. (192) 169)
Dexmedetomidine
Nucleus tractus solitarii slices; [*HJNoradrenaline release; Yohim-
a,-Adrenoceptors; Antinociception; (Intrathecal) (Fisher, B. (192)
bine; a,-Adrenoceptors; Opioid receptor agonists (selective); u-Opioid
221)
receptors; (Rat) (Arakawa, K. (192) 311)
a-Adrenoceptor agonists; Analgesia; Analgesics; Clonidine; a-Adren-
Cocaine
oceptors; Spinal cord (neonatal rat) (Kendig, J.J. (192) 293)
Analgesia; Naloxone; Thalamus; Formalin test; Pain (mechanical);
(Rat) (Pertovaara, A. (192) 349)
Dextromethorphan
Calcium channels (voltage-sensitive); Verapamil; Diltiazem; Neuro-
Compound 48/80
transmitter release; w-Conotoxin GVIA (Mangano, T.J. (192) 9)
Mast cells; BrX-537 A; 5-HT (5-hydroxytryptamine, serotonin); 5-HT
receptor; Small intestine; Motility (Bueno, L. (192) 263) Diazepam
Dystonia; GABA (y-aminobutyric acid); Valproate; Phenobarbital;
w-Conotoxin GVIA Phenytoin; Carbamazepine; Baclofen; Pentylenetetrazol (Fredow, G.
Calcium channels (voltage-sensitive); Verapamil; Diltiazem; Dextro- (192) 207)
methorphan; Neurotransmitter release (Mangano, T.J. (192) 9)
Diltiazem
Contraction Calcium channels (voltage-sensitive); Verapamil; Dextromethorphan;
Ethanol; NMDA receptors; Myentric plexus (Frye, G.D. (192) 1) Neurotransmitter release; w-Conotoxin GVIA (Mangano, T.J. (192)
9)
Coronary circulation
Diproteverine
Endothelins; Transmural flow; Myocardial ischaemia; Endothelium
Ca?* channel antagonists; Haemodynamic effects; Coronary flow
(Domenech, R. (192) 409)
redistribution; Myocardial metabolism (Lacroix, P. (192) 317)
Coronary flow redistribution
Diuretics (high ceiling)
Ca** channel antagonists; Diproteverine; Haemodynamic effects;
Diuretics (low ceiling); [Arg®]vasopressin (AVP); cAMP; Renal cells
Myocardial metabolism (Lacroix, P. (192) 317)
(cultured, rat); Renal cells (cultured, dog) (Kanda, K. (192) 153)
Corticosteroids
Diuretics (low ceiling)
Interleukin-1; a-MSH (a-melanocyte-stimulating hormone); ACTH;
Diuretics (high ceiling); [Arg®]vasopressin (AVP); cAMP; Renal cells
Immunosuppression; Natural Killer cell activity (Weiss, J.M. (192)
(cultured, rat); Renal cells (cultured, dog) (Kanda, K. (192) 153)
177)
Dopamine
Coupled beats Ritanserin; 5-HT, receptor antagonists; Microdialysis (Devaud, L.L.
Lysophosphatidylcholine; Carnitine; Reperfusion arrhythmias; Auto- (192) 427)
maticity (Duan, J. (192) 355)
Dopamine DA, receptors
Creatine phosphokinase Dopamine DA, receptors; Circle of Willis arteries; Pial-arachnoid
a-Tocopherol derivatives; Myocardial ischaemia/reperfusion; Free arteries; Radioreceptor binding; Autoradiography (Amenta, F. (192)
radicals; Radical scavenger (Petty, M.A. (192) 383) 123)
456
Dopamine DA , receptors Free radicals
Dopamine DA, receptors; Circle of Willis arteries; Pial-arachnoid a-Tocopherol derivatives; Myocardial ischaemia/reperfusion; Crea-
arteries; Radioreceptor binding; Autoradiography (Amenta, F. (192) tine phosphokinase; Radical scavenger (Petty, M.A. (192) 383)
123)
GABA (y-aminobutyric acid)
Baclofen; Cardiovascular control; Spinal cord; Sympathetic output;
Dopamine release
Heart rate; Arterial pressure (Hong, Y. (192) 55)
Haloperidol; Striatal slices (rat) (Yamada, S. (192) 141)
Dystonia; Diazepam; Valproate; Phenobarbital; Phenytoin; Carba-
Dystonia
mazepine; Baclofen; Pentylenetetrazol (Fredow, G. (192) 207)
GABA (y-aminobutyric acid); Diazepam; Valproate; Phenobarbital;
Phenytoin; Carbamazepine; Baclofen; Pentylenetetrazol (Fredow, G.
GABA, receptors
(192) 207)
Somatostatin; Septum; G-proteins (guanine nucleotide-binding pro-
teins); Pertussis toxin; K* channels (Twery, M.J. (192) 287)
Efferent function of sensory nerves
CGRP (calcitonin gene-related peptide); CGRP receptor antagonists;
Gastric acid secretion
Capsaicin; Afferents (primary) (Maggi, C.A. (192) 85) Ulceration; Gastric mucus; Morphine; Indomethacin; Aspirin;
Taurocholic acid (Tazi-Saad, K. (192) 271)
Electromechanical coupling
Smooth muscle; Vas deferens (human); Vas deferens (rat); Thiorida- Gastric mucus
zine; Ca**-free media (Amobi, N. (192) 343)
Gastric acid secretion; Ulceration; Morphine; Indomethacin; Aspirin;
Taurocholic acid (Tazi-Saad, K. (192) 271)
Electrophysiology
AH 21-132 (and enantiomers); Trachealis muscle (guinea-pig); Muscle L-Glutamate
fibres (skinned); Phosphodiesterase inhibition; Nucleotides (cyclic) NMDA (N-methyl-D-aspartate); Excitatory amino acid (Sills, M.A.
(Small, R.C. (192) 417) (192) 19)
Emesis Glyceryl trinitrate
Benzamides; Zacopride; 5-HT receptor antagonists; (Ferret); (Stereo- Isobutyl nitrate; Isobutyl nitrite; Tolerance (in vitro); Aortic strips
isomers) (Sancilio, L.F. (192) 365) (rabbit) (Zimmermann, T. (192) 181)
Glycyl-L-glutamine
Endothelins
Arachidonic acid; Proopiomelanocortin peptides; NMDA (N-methyl-
BAY k 8644; Oxytocic agents; Uterus (rat); Nicardipine; Pregnancy
D-aspartate); Phencyclidine/o receptors; Cultured neurones (Haynes,
(Calixto, J.B. (192) 109)
L. (192) 397)
Coronary circulation; Transmural flow; Myocardial ischaemia; Endo-
cGMP
thelium (Domenech, R. (192) 409)
Vasorelaxation (rat aorta); Norathyriol; Ca** influx (Ko, F.-N. (192)
133)
Endothelium
Cerebral arteries; Blood flow (cerebral); Ca**; Nicardipine; BAY k
G-proteins (guanine nucleotide-binding proteins)
8644 (Salom, J.B. (192) 39)
Somatostatin; Septum; Pertussis toxin; K* channels; GABA, recep-
tors (Twery, M.J. (192) 287)
Endothelins; Coronary circulation; Transmural flow; Myocardial
ischaemia (Domenech, R. (192) 409) Haemodynamic effects
Ca** channel antagonists; Diproteverine; Coronary flow redistribu-
Enkephalin metabolism tion; Myocardial metabolism (Lacroix, P. (192) 317)
Morphine; Antinociception; Kelatorphan; Naloxone; RB 38A inhibi-
tors (mixed); (Mouse); (Rat) (Schmidt, C. (192) 253) Haloperidol
Dopamine release; Striatal slices (rat) (Yamada, S. (192) 141)
Enkephalins
Heart rate
Opioid antinociception; 6-Opioid receptors; p-Opioid receptors;
Baclofen; GABA (y-aminobutyric acid); Cardiovascular control; Spi-
DALES ({D-Ala*,Leu°,Ser° Jenkephalin); (Intracerebroventricular)
nal cord; Sympathetic output; Arterial pressure (Hong, Y. (192) 55)
(Mattia, A. (192) 371)
Hippocampal slices
Ethanol
Quisqualic acid; L-2-Amino-4-phosphonobutanoic acid (L-AP4);
NMDA receptors; Myentric plexus; Contraction (Frye, G.D. (192) 1)
Sensitization; Excitatory amino acids (Whittemore, E.R. (192) 435)
Excitatory amino acid
5-HT (5-hydroxytryptamine, serotonin)
NMDA (N-methyl-D-aspartate); L-Glutamate (Sills, M.A. (192) 19)
Respiratory activity (central); 5-HT synthesis; (Newborn); (In vitro)
(Morin, D. (192) 89)
Excitatory amino acids
Quisqualic acid; L-2-Amino-4-phosphonobutanoic acid (L-AP4); Mast cells; Compound 48/80; BrX-537 A; 5-HT receptor; Small
Sensitization; Hippocampal slices (Whittemore, E.R. (192) 435)
intestine; Motility (Bueno, L. (192) 263)
Formalin test 5-HT receptor
Analgesia; Cocaine; Naloxone; Thalamus; Pain (mechanical); (Rat) Mast cells; Compound 48/80; BrX-537 A; 5-HT (5-hydroxytrypta-
(Pertovaara, A. (192) 349) mine, serotonin); Small intestine; Motility (Bueno, L. (192) 263)
5-HT,, receptor agonists Islet amyloid polypeptide
Learned helplessness; Antidepressant drugs; (Rats) (Martin, P. (192) Insulin secretion; (In vivo); (In vitro); (Rat) (Ar Rajab, A. (192) 443)
193)
Isobutyl nitrate
5-HT receptor antagonists Isobutyl nitrite; Glyceryl trinitrate; Tolerance (in vitro); Aortic strips
Benzamides; Zacopride; Emesis; (Ferret); (Stereoisomers) (Sancilio, (rabbit) (Zimmermann, T. (192) 181)
L.F. (192) 365)
Isobutyl nitrite
5-HT, receptor antagonists Isobutyl nitrate; Glyceryl trinitrate; Tolerance (in vitro); Aortic strips
Ritanserin; Microdialysis; Dopamine (Devaud, L.L. (192) 427) (rabbit) (Zimmermann, T. (192) 181)
5-HT, receptors Isoprenaline
Quipazine; Hypertension; Splanchnic nerve activity; Ventrolateral Smooth muscle (aortic); Nitrovasodilator; Synergism; (Rat) (Maurice,
pressor area (Vayssettes-Courchay, C. (192) 389) D.H. (192) 235)
5-HT synthesis Isradipine
5-HT (5-hydroxytryptamine, serotonin); Respiratory activity (central); Catecholamine release; Adrenal medulla (Cardenas, A.M. (192) 243)
(Newborn); (In vitro) (Morin, D. (192) 89)
K* channels
Vas deferens (rat); Noradrenaline; Naphazoline; Cromakalim;
Hydralazine
ANF (atrial natriuretic factor); Spontaneously hypertensive rats Verapamil (Grana, E. (192) 79)
(SHR); Volume expansion; Atrial pressure; Na* excretion (Lachance,
Somatostatin; Septum; G-proteins (guanine nucleotide-binding pro-
D. (192) 301)
teins); Pertussis toxin; GABA, receptors (Twery, M.J. (192) 287)
Hypertension
Kelatorphan
Muscarinic acetylcholine receptors; Pulmonary artery; Pulmonary
Enkephalin metabolism; Morphine; Antinociception; Naloxone; RB
vein; Autoradiography (De Michele, M. (192) 71)
38A inhibitors (mixed); (Mouse); (Rat) (Schmidt, C. (192) 253)
Renin inhibitors; Sodium depletion; Plasma renin activity; (Consci-
Ketamine
ous marmoset) (Gardner, C.J. (192) 329)
NMDA receptor antagonists (non-competitive); Phencyclidine; MK-
801; (Pig) (Léscher, W. (192) 377)
Quipazine; Splanchnic nerve activity; Ventrolateral pressor area; 5-
HT, receptors (Vayssettes-Courchay, C. (192) 389)
Labour
Interleukin-6; Prostaglandin biosynthesis; Amnion; Decidua
Ileum (guinea-pig)
(Mitchell, M.D. (192) 189)
Myenteric neurons; p-Opioids (Pillai, N.P. (192) 227)
Learned helplessness
Immunosuppression
Antidepressant drugs; 5-HT,, receptor agonists; (Rats) (Martin, P.
Interleukin-1; a-MSH (a-melanocyte-stimulating hormone); ACTH;
(192) 193)
Corticosteroids; Natural Killer cell activity (Weiss, J.M. (192) 177)
Locomotor activity
Indomethacin
Reserpine; Bromocriptine; Adenosine analogues; (Mouse) (Ferré, S.
Cyclooxygenase inhibitors; Insulin; Interleukin-1; Prostaglandin;
(192) 25)
(Rat) (Uehara, A. (192) 185)
Reserpine; Bromocriptine; Methylxanthines; NECA (5’-(N-ethyl)-
Gastric acid secretion; Ulceration; Gastric mucus; Morphine; Aspirin;
carboxamido-adenosine); (Mouse) (Ferré, S. (192) 31)
Taurocholic acid (Tazi-Saad, K. (192) 271)
Lysophosphatidylcholine
Insulin Carnitine; Reperfusion arrhythmias; Coupled beats; Automaticity
Cyclooxygenase inhibitors; Indomethacin; Interleukin-1; Prostaglan-
(Duan, J. (192) 355)
din; (Rat) (Uehara, A. (192) 185)
Macrophage functions (peritoneal)
Insulin secretion Splanchnic artery occlusion shock; PAF (platelet activating factor,
Islet amyloid polypeptide; (In vivo); (In vitro); (Rat) (Ar’Rajab, A. PAF-acether); TNF, (tumor necrosis factor); Thromboxane B,
(192) 443) (Squadrito, F. (192) 47)
Interleukin-1 Mast cells
a-MSH (a-melanocyte-stimulating hormone); ACTH; Corti- Cimetidine; Nifedipine; Stress ulcers (Al-Mashhadani, W.M. (192)
costeroids; Immunosuppression; Natural Killer cell activity (Weiss, 117)
J.M. (192) 177)
Compound 48/80; BrX-537 A; 5-HT (5-hydroxytryptamine,
Cyclooxygenase inhibitors; Indomethacin; Insulin; Prostaglandin; serotonin); 5-HT receptor; Small intestine; Motility (Bueno, L. (192)
(Rat) (Uehara, A. (192) 185) 263)
Interleukin-6 MCI-154
Prostaglandin biosynthesis; Amnion; Decidua; Labour (Mitchell, Cardiotonic agents; Reperfusion; Postischemic dysfunction; (Dog)
M.D. (192) 189) (Abe, Y. (192) 279)
458
Methoctramine Na* excretion
Muscarinic receptor subtypes; Cardioselectivity; Cardiac muscarinic ANF (atrial natriuretic factor); Spontaneously hypertensive rats
M,,, receptors; Prostaglandin synthesis (Jaiswal, N. (192) 63) (SHR); Volume expansion; Atrial pressure; Hydralazine (Lachance,
D. (192) 301)
Methoxamine
Artery (caudal); Norepinephrine; Neuromodulation; Adenine Naloxone
nucleotides; Adenine nucleosides (Shinozuka, K. (192) 431) Enkephalin metabolism; Morphine; Antinociception; Kelatorphan;
RB 38A inhibitors (mixed); (Mouse); (Rat) (Schmidt, C. (192) 253)
Methylxanthines
Reserpine; Bromocriptine; NECA (5’-(N-ethyl)carboxamido-adeno- Analgesia; Cocaine; Thalamus; Formalin test; Pain (mechanical);
sine); Locomotor activity; (Mouse) (Ferré, S. (192) 31) (Rat) (Pertovaara, A. (192) 349)
Microdialysis Naphazoline
Ritanserin; 5-HT, receptor antagonists; Dopamine (Devaud, L.L. Vas deferens (rat); Noradrenaline; Cromakalim; Verapamil; K*
(192) 427) channels (Grana, E. (192) 79)
MK-801 Natural Killer cell activity
NMDA receptor antagonists (non-competitive); Ketamine; Phen- Interleukin-1; a-MSH (a-melanocyte-stimulating hormone); ACTH;
cyclidine; (Pig) (Léscher, W. (192) 377) Corticosteroids; Immunosuppression (Weiss, J.M. (192) 177)
Morphine NECA (5’ -(N-ethyl)carboxamido-adenosine)
Enkephalin metabolism; Antinociception; Kelatorphan; Naloxone; Reserpine; Bromocriptine; Methylxanthines; Locomotor activity;
RB 38A inhibitors (mixed); (Mouse); (Rat) (Schmidt, C. (192) 253) (Mouse) (Ferré, S. (192) 31)
Gastric acid secretion; Ulceration; Gastric mucus; Indomethacin; Neurological deficits
Aspirin; Taurocholic acid (Tazi-Saad, K. (192) 271) SHR (stroke-prone, SHRSP); YM-14673; TRH analogues (Yama-
moto, M. (192) 165)
Motility
Mast cells; Compound 48/80; BrX-537 A; 5-HT (5-hydroxytrypta- Neuromodulation
mine, serotonin); 5-HT receptor; Small intestine (Bueno, L. (192) 263) Artery (caudal); Norepinephrine; Methoxamine; Adenine nucleo-
tides; Adenine nucleosides (Shinozuka, K. (192) 431)
a-MSH (a-melanocyte-stimulating hormone)
Interleukin-1; ACTH; Corticosteroids; Immunosuppression; Natural Neuropeptide y
Killer cell activity (Weiss, J.-M. (192) 177) Substance P; Cardiovascular regulation; Tachykinin peptides (Hagio,
T. (192) 173)
Muscarinic acetylcholine receptors
Hypertension; Pulmonary artery; Pulmonary vein; Autoradiography Neuropeptide Y
Ca** channels (voltage-sensitive); Ca?* influx (Lundy, P.M. (192)
(De Michele, M. (192) 71)
439)
Muscarinic M, receptors
AQ-RA 741; Cardioselective muscarinic receptor antagonists (Doods, Neurotransmitter release
H. (192) 147) Calcium channels (voltage-sensitive); Verapamil; Diltiazem; Dextro-
methorphan; w-Conotoxin GVIA (Mangano, T.J. (192) 9)
Muscarinic receptor subtypes
Methoctramine; Cardioselectivity; Cardiac muscarinic M,, receptors; Nicardipine
Prostaglandin synthesis (Jaiswal, N. (192) 63) Cerebral arteries; Blood flow (cerebral); Endothelium; Ca**:; BAY k
8644 (Salom, J.B. (192) 39)
Muscle fibres (skinned)
AH 21-132 (and enantiomers); Trachealis muscle (guinea-pig); Phos- Endothelins; BAY k 8644; Oxytocic agents; Uterus (rat); Pregnancy
phodiesterase inhibition; Nucleotides (cyclic); Electrophysiology (Calixto, J.B. (192) 109)
(Small, R.C. (192) 417)
Nifedipine
Myenteric neurons Cimetidine; Mast cells; Stress ulcers (Al-Mashhadani, W.M. (192)
Ileum (guinea-pig); w-Opioids (Pillai, N.P. (192) 227) 117)
Myentric plexus Nitrovasodilator
Ethanol; NMDA receptors; Contraction (Frye, G.D. (192) 1) Smooth muscle (aortic); Isoprenaline; Synergism; (Rat) (Maurice,
D.H. (192) 235)
Myocardial ischaemia
Endothelins; Coronary circulation; Transmural flow; Endothelium NMDA (N-methyl-D-aspartate)
(Domenech, R. (192) 409) Excitatory amino acid; L-Glutamate (Sills, M.A. (192) 19)
Myocardial ischaemia/reperfusion (SHJTCP ({?HJN-[1-(2-thienyl)cyclohexyl]-3,4-piperidine) (in vivo
a-Tocopherol derivatives; Creatine phosphokinase; Free radicals; binding); Desipramine; Tricyclic antidepressants; BTCP (N-[1-(2-
Radical scavenger (Petty, M.A. (192) 383) benzo(b)thiophenyl)cyclohexyl]piperidine); Phencyclidine (Maurice, T.
(192) 169)
Myocardial metabolism
Ca** channel antagonists; Diproteverine; Haemodynamic effects; Glycyl-L-glutamine; Arachidonic acid; Proopiomelanocortin peptides;
Coronary flow redistribution (Lacroix, P. (192) 317) Phencyclidine/o receptors; Cultured neurones (Haynes, L. (192) 397)